Camptothecin derivatives

C - Chemistry – Metallurgy – 08 – B

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C08B 37/00 (2006.01) A61K 31/715 (2006.01) A61K 38/14 (2006.01) A61K 47/48 (2006.01) C07D 491/22 (2006.01) C07K 5/065 (2006.01) C07K 5/103 (2006.01) C07K 9/00 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2182244

The present invention is directed to a camptothecin derivative comprising a compound of the formula [I]: (see formula (I) wherein R1 is a substituted or unsubstituted lower alkyl group, X1 is a group of the formula: -NHR2 (R2 is a hydrogen atom or a lower alkyl group) or a group of -OH, and Alk is a straight chain or branched chain alkylene group having optionally an oxygen atom in the chain thereof, bound to a polysaccharide having carboxyl groups via an amino acid or a peptide, or a pharmaceutically acceptable salt thereof. Said camptothecin derivatives show enhanced antitumor activities but few side effects unlike conventional anticancer agents, and hence, these compounds are extremely useful as a medicament.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Camptothecin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Camptothecin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Camptothecin derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2091400

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.